Maternal and neonatal outcomes in mothers with diabetes mellitus in qatari population

Mohammad A A Bayoumi1, Razan M Masri2, Nada Y S Matani2

  • 1Neonatal Intensive Care Unit (NICU), Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), Doha, P.O. Box 3050, Qatar. moh.abdelwahab@hotmail.com.

BMC Pregnancy and Childbirth
|September 25, 2021
PubMed

Insights

Maternal diabetes mellitus (DM) in Qatar is linked to increased newborn birth weight and macrosomia. Improving adherence to diabetic control programs and addressing pre-pregnancy obesity are crucial for better outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Endocrinology

Background:

  • Diabetes Mellitus (DM) significantly contributes to maternal, fetal, and neonatal complications.
  • Understanding the impact of pre-pregnancy and gestational DM on newborn growth is vital for public health in Qatar.

Purpose of the Study:

  • To evaluate the effects of pre-pregnancy and gestational diabetes mellitus on newborn growth parameters in the Qatari population.
  • To identify risk factors associated with gestational diabetes mellitus.

Main Methods:

  • A population-based cohort study comparing neonates of Qatari women with pre-pregnancy DM or gestational DM (GDM) to those of healthy non-diabetic women in 2017.
  • Analysis included birth weight, length, head circumference, congenital malformations, and macrosomia rates.
  • Multivariate logistic regression was used to identify risk factors for GDM.

Main Results:

  • The prevalence of GDM among Qatari women in 2017 was 24.25%.
  • Infants born to mothers with GDM or pre-pregnancy DM showed increased mean birth weight and a higher prevalence of macrosomia compared to controls.
  • Higher maternal age, pre-pregnancy obesity, C-section delivery, and large-for-gestational-age (LGA) status were significantly associated with increased GDM risk.

Conclusions:

  • Despite antenatal care, infants of diabetic mothers exhibit increased birth weight and macrosomia.
  • Enhanced adherence to diabetic control programs and pre-conceptional counseling focusing on BMI are recommended.
  • Pre-pregnancy obesity is a significant modifiable risk factor for gestational DM.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
572